Work

Empagliflozin in combination with oral agents in young and overweight/obese Type 2 diabetes mellitus patients: A pooled analysis of three randomized trials

Year: 2016

Type: article

Source: Journal of Diabetes and its Complications

DOI: 10.1016/j.jdiacomp.2016.07.016

Authors: Irene Romera, Ramon Gomis, Susanne Crowe, Pedro de Pablos-Velasco, Unai Aranda, Arantxa García, Sanja Giljanovic Kis, Ebrahim Naderali

Institutions: Eli Lilly (Spain), Hospital Clínic de Barcelona, Boehringer Ingelheim (Germany), Universidad de Las Palmas de Gran Canaria, Hospital Universitario de Gran Canaria Doctor Negrín, Boehringer Ingelheim (Spain), Eli Lilly (United Kingdom), Liverpool Hope University

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Eli Lilly and Company

OpenAlex ID: W2498155300

FWCI: 0.512

Cites: 22

Cited by: 9

Related to: 10